Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.600
+0.100 (6.67%)
At close: Nov 22, 2024, 4:00 PM
1.680
+0.080 (5.00%)
After-hours: Nov 22, 2024, 7:41 PM EST

Kairos Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3.220.090.440.07
Cash & Short-Term Investments
3.220.090.440.07
Cash Growth
3149.49%-78.72%498.63%-
Prepaid Expenses
0.010.01--
Total Current Assets
4.740.10.440.07
Other Intangible Assets
0.260.380.540.7
Long-Term Deferred Charges
-0.480.06-
Total Assets
50.971.040.78
Accounts Payable
1.532.41.631.55
Short-Term Debt
0.14000.39
Total Current Liabilities
1.672.411.631.94
Long-Term Debt
-0.640.58-
Total Liabilities
1.673.042.221.94
Common Stock
0.010.010.010.1
Additional Paid-In Capital
11.154.123.212.08
Retained Earnings
-7.84-6.21-4.4-3.35
Shareholders' Equity
3.33-2.08-1.18-1.17
Total Liabilities & Equity
50.971.040.78
Total Debt
0.140.640.590.39
Net Cash (Debt)
3.08-0.55-0.15-0.32
Net Cash Per Share
0.29-0.05-0.01-0.04
Filing Date Shares Outstanding
12.8510.5610.339.15
Total Common Shares Outstanding
12.8510.5610.339.15
Working Capital
3.07-2.3-1.2-1.87
Book Value Per Share
0.26-0.20-0.11-0.13
Tangible Book Value
3.07-2.46-1.72-1.87
Tangible Book Value Per Share
0.24-0.23-0.17-0.20
Source: S&P Capital IQ. Standard template. Financial Sources.